Sanofi India500674Show cause notice

GST Show Cause Notice of Rs. 23,73,76,507 Received Over Alleged Excess Input Tax Credit for FY 2022-23

Sanofi India has received a Show Cause Notice from Karnataka GST authorities alleging excess Input Tax Credit claimed for April 2022 to March 2023.

By ScoutQuest · Fri 25 Sep 2026, 10:32 PM IST · 1 min read

Tax Demand: Rs.14,43,01,828
Interest: Rs.9,30,74,679
Total Liability: Rs. 23,73,76,507
Period: April 2022 to March 2023
Allegation: Excess Input Tax Credit claimed

What was shared

Sanofi India informed the exchanges that it has received a Show Cause Notice under Section 73 of the Karnataka Goods and Services Tax Act, 2017.

The allegation

Issued by the Commercial Tax Officer (Audit)-6.1, DGSTO-6, Bengaluru.
Alleges the company availed excess Input Tax Credit for the period April 2022 to March 2023 (FY 2022-23).

Amounts involved

Proposed tax liability: Rs.14,43,01,828
Interest: Rs.9,30,74,679
Aggregate: Rs. 23,73,76,507

What Input Tax Credit means

Input Tax Credit lets a business offset GST it paid on purchases against GST it collects on sales. Authorities are alleging more credit was claimed than permitted for that year.

Company's position

The company is in the process of responding to the notice after obtaining the relevant facts on which the demand was determined.
It is examining the notice with its consultants and tax advisors and will submit a reply within the prescribed time.
It states it does not envisage any adverse impact on the financials, operations or other activities arising from this notice.

How to read this

A Show Cause Notice is a preliminary step, not a final order. The company gets an opportunity to reply before any demand is confirmed, and such matters can move to appellate forums. The disclosed aggregate of Rs. 23,73,76,507 is the amount at stake as proposed today.

Also from Sanofi India